搜尋





搜尋





Quince Therapeutics Inc

QNCX

添加自選

34.475USD

+0.435+1.28%

交易中（美東）報價延遲15分鐘

23.77M總市值

1.52本益比TTM

Quince Therapeutics Inc

34.475

+0.435+1.28%

財務摘要利潤表資產負債表現金流量表財報公司估值風險評估

概覽

新聞分析

財務

股票評分

技術分析

預測

持股情況

股息

公司資料

財務摘要利潤表資產負債表現金流量表財報公司估值風險評估

QNCX 利潤表

您可以在這裡找到Quince Therapeutics Inc的年度或季度收入報告，以深入了解Quince Therapeutics Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q3

FY2018Q2

FY2018Q1

營業費用

110.03%20.78M

-24.84%9.72M

60.61%16.24M

32.97%11.36M

11.91%9.89M

49.13%12.93M

21.17%10.11M

40.24%8.55M

58.35%8.84M

22.92%8.67M

32.03%8.34M

-10.32%6.09M

-65.65%5.58M

-67.73%7.06M

-73.16%6.32M

-68.65%6.79M

-25.36%16.26M

-6.22%21.86M

12.91%23.54M

-1.07%21.68M

19.22%21.78M

30.55%23.31M

61.03%20.85M

107.32%21.91M

90.82%18.27M

193.96%17.86M

--12.95M

267.75%10.57M

262.28%9.57M

120.11%6.08M

--2.87M

--2.64M

--2.76M

研發費用

-34.08%5.46M

-20.10%7.91M

116.33%12.60M

50.76%9.78M

66.18%8.28M

115.45%9.90M

69.63%5.83M

353.39%6.49M

268.44%4.99M

42.26%4.59M

24.06%3.43M

-41.62%1.43M

-81.21%1.35M

-74.68%3.23M

-81.81%2.77M

-82.54%2.45M

-51.09%7.20M

-24.17%12.76M

-4.06%15.21M

-17.34%14.04M

4.49%14.72M

17.00%16.82M

58.14%15.86M

105.78%16.98M

98.14%14.09M

198.03%14.38M

--10.03M

260.39%8.25M

210.98%7.11M

99.96%4.83M

--2.29M

--2.41M

折舊攤銷及損耗

----

12.50%36.00K

143.75%39.00K

-58.14%36.00K

-20.45%35.00K

-20.00%32.00K

-94.74%16.00K

--86.00K

1366.67%44.00K

135.29%40.00K

623.81%304.00K

-100.00%0.00

-96.43%3.00K

-55.26%17.00K

-50.00%42.00K

-54.02%40.00K

-3.45%84.00K

-55.81%38.00K

-1.18%84.00K

3.57%87.00K

8.75%87.00K

3.61%86.00K

11.84%85.00K

42.37%84.00K

135.29%80.00K

336.84%83.00K

--76.00K

490.00%59.00K

277.78%34.00K

137.50%19.00K

--10.00K

--9.00K

--8.00K

營業利潤

-706.29%-79.78M

24.84%-9.72M

-60.61%-16.24M

-32.97%-11.36M

-11.91%-9.89M

-49.13%-12.93M

-21.17%-10.11M

-40.24%-8.55M

-58.35%-8.84M

-22.92%-8.67M

-32.03%-8.34M

10.32%-6.09M

65.65%-5.58M

67.73%-7.06M

73.16%-6.32M

68.65%-6.79M

25.36%-16.26M

6.22%-21.86M

-12.91%-23.54M

1.07%-21.68M

-19.22%-21.78M

-30.55%-23.31M

-61.03%-20.85M

-107.32%-21.91M

-90.82%-18.27M

-193.96%-17.86M

---12.95M

-267.75%-10.57M

-262.28%-9.57M

-120.11%-6.08M

---2.87M

---2.64M

---2.76M

淨非營業利息收入（費用）

利息收入

87.78%584.00K

-60.59%160.00K

-57.65%227.00K

-56.08%300.00K

-62.21%311.00K

-54.23%406.00K

-47.14%536.00K

-28.78%683.00K

2.24%823.00K

26.71%887.00K

89.18%1.01M

204.44%959.00K

455.17%805.00K

872.22%700.00K

410.48%536.00K

146.09%315.00K

-9.38%145.00K

-68.28%72.00K

-64.65%105.00K

-68.47%128.00K

-75.72%160.00K

-66.72%227.00K

-47.89%297.00K

-42.90%406.00K

28.46%659.00K

73.10%682.00K

--570.00K

101.42%711.00K

533.33%513.00K

--394.00K

--353.00K

--81.00K

--0.00

利息費用

----

--0.00

-100.00%0.00

--0.00

--358.00K

--599.00K

特殊收入（費用）

-867.58%-53.19M

1722.26%38.41M

-788.26%-20.96M

-204.03%-2.32M

72.19%-5.50M

19.26%-2.37M

-23.17%-2.36M

--2.23M

---19.77M

50.84%-2.93M

---1.92M

100.00%0.00

--0.00

---5.97M

--0.00

---825.00K

----

--0.00

100.00%0.00

--0.00

---188.00K

---18.00K

其他非經營性收入（費用）

19.87%-722.00K

2075.86%1.72M

227.41%660.00K

-166.67%-100.00K

-1090.11%-901.00K

78.20%-87.00K

-228.86%-518.00K

169.44%150.00K

185.05%91.00K

-121.67%-399.00K

61.45%402.00K

64.94%-216.00K

85.44%-107.00K

-220.00%-180.00K

522.50%249.00K

-292.36%-616.00K

-461.07%-735.00K

--150.00K

--40.00K

---157.00K

---131.00K

----

稅前利潤

-371.86%-75.41M

304.05%30.57M

-191.64%-36.31M

-146.18%-13.49M

42.29%-15.98M

-34.76%-14.98M

-40.80%-12.45M

-2.39%-5.48M

-466.78%-27.69M

11.07%-11.12M

-59.79%-8.84M

32.45%-5.35M

71.00%-4.89M

42.23%-12.50M

76.35%-5.53M

63.51%-7.92M

22.55%-16.85M

6.26%-21.64M

-13.84%-23.40M

-0.93%-21.71M

-23.52%-21.75M

-34.41%-23.09M

-66.05%-20.55M

-118.16%-21.51M

-94.35%-17.61M

-202.34%-17.18M

---12.38M

-291.04%-9.86M

-191.57%-9.06M

-68.23%-5.68M

---2.52M

---3.11M

---3.38M

所得稅

11.94%75.00K

-11459.57%-5.34M

44842.86%3.15M

-453.85%-46.00K

86.11%67.00K

51.61%47.00K

-86.27%7.00K

--13.00K

--36.00K

112.50%31.00K

--51.00K

--0.00

100.00%0.00

---248.00K

--0.00

---284.00K

----

除稅後利潤

-370.36%-75.49M

338.94%35.91M

-216.73%-39.46M

-144.76%-13.44M

42.12%-16.05M

-34.81%-15.03M

-40.07%-12.46M

-2.64%-5.49M

-467.52%-27.73M

9.02%-11.15M

-60.72%-8.89M

32.45%-5.35M

70.50%-4.89M

43.38%-12.25M

76.35%-5.53M

63.51%-7.92M

23.86%-16.56M

6.26%-21.64M

-13.84%-23.40M

-0.93%-21.71M

-23.52%-21.75M

-34.41%-23.09M

-66.05%-20.55M

-118.16%-21.51M

-94.35%-17.61M

-202.34%-17.18M

---12.38M

-291.04%-9.86M

-191.57%-9.06M

-68.23%-5.68M

---2.52M

---3.11M

---3.38M

持續經營利潤

----

338.94%35.91M

-216.73%-39.46M

-144.76%-13.44M

42.12%-16.05M

-34.81%-15.03M

-40.07%-12.46M

-2.64%-5.49M

-467.52%-27.73M

9.02%-11.15M

-60.72%-8.89M

32.45%-5.35M

70.50%-4.89M

43.38%-12.25M

76.35%-5.53M

63.51%-7.92M

23.86%-16.56M

6.26%-21.64M

-13.84%-23.40M

-0.93%-21.71M

-23.52%-21.75M

-34.41%-23.09M

-66.05%-20.55M

-118.16%-21.51M

-94.35%-17.61M

-202.34%-17.18M

---12.38M

-291.04%-9.86M

-191.57%-9.06M

-68.23%-5.68M

---2.52M

---3.11M

---3.38M

歸属于母公司的淨利潤

----

338.94%35.91M

-216.73%-39.46M

-144.76%-13.44M

42.12%-16.05M

-34.81%-15.03M

-40.07%-12.46M

-2.64%-5.49M

-467.52%-27.73M

9.02%-11.15M

-60.72%-8.89M

32.45%-5.35M

70.50%-4.89M

43.38%-12.25M

76.35%-5.53M

63.51%-7.92M

23.86%-16.56M

6.26%-21.64M

-13.84%-23.40M

-0.93%-21.71M

-23.52%-21.75M

-34.41%-23.09M

-66.05%-20.55M

-118.16%-21.51M

-94.35%-17.61M

-202.34%-17.18M

---12.38M

-291.04%-9.86M

-191.57%-9.06M

-68.23%-5.68M

---2.52M

---3.11M

---3.38M

歸屬普通股東的淨利潤

----

338.94%35.91M

-216.73%-39.46M

-144.76%-13.44M

42.12%-16.05M

-34.81%-15.03M

-40.07%-12.46M

-2.64%-5.49M

-467.52%-27.73M

9.02%-11.15M

-60.72%-8.89M

32.45%-5.35M

70.50%-4.89M

43.38%-12.25M

76.35%-5.53M

63.51%-7.92M

23.86%-16.56M

6.26%-21.64M

-13.84%-23.40M

-0.93%-21.71M

-23.52%-21.75M

-34.41%-23.09M

-66.05%-20.55M

-118.16%-21.51M

-94.35%-17.61M

-202.34%-17.18M

---12.38M

-291.04%-9.86M

-191.57%-9.06M

-68.23%-5.68M

---2.52M

---3.11M

---3.38M

基本每股收益

82.10%-12.31

23123.53%78.75

-2389.99%-7.09

-95.81%-0.25

46.57%-0.34

-31.95%-0.34

-31.59%-0.28

14.22%-0.13

-373.00%-0.64

24.15%-0.26

-39.57%-0.22

33.31%-0.15

73.34%-0.14

52.41%-0.34

80.16%-0.15

69.50%-0.22

30.61%-0.51

8.06%-0.72

-12.11%-0.78

0.02%-0.73

-22.92%-0.74

-28.53%-0.78

-66.91%-0.70

-98.57%-0.73

-77.17%-0.60

-178.29%-0.61

---0.42

51.04%-0.37

-182.57%-0.34

-68.23%-0.22

---0.75

---0.12

---0.13

稀釋每股收益

82.10%-12.31

22948.00%78.15

-2389.99%-7.09

-95.81%-0.25

46.57%-0.34

-31.95%-0.34

-31.59%-0.28

14.22%-0.13

-373.00%-0.64

24.15%-0.26

-39.57%-0.22

33.31%-0.15

73.34%-0.14

52.41%-0.34

80.16%-0.15

69.50%-0.22

30.61%-0.51

8.06%-0.72

-12.11%-0.78

0.02%-0.73

-22.92%-0.74

-28.53%-0.78

-66.91%-0.70

-98.57%-0.73

-77.17%-0.60

-178.29%-0.61

---0.42

51.04%-0.37

-182.57%-0.34

-68.23%-0.22

---0.75

---0.12

---0.13

每股派息

----

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Quince Therapeutics Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 QNCX 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Quince Therapeutics Inc 全年的淨利潤是多少？



Quince Therapeutics Inc 2025 財年淨利潤為 -83.98M。

Quince Therapeutics Inc 年度營業利潤是多少？



Quince Therapeutics Inc 2025 財年的營業利潤為 -50.43M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。